Fengyan Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Population Pharmacokinetics of Serplulimab and Quantitative Assessment of Transitioning From Weight-Based to Flat-Dosing Strategy.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 27, 2025
Population Pharmacokinetics for Pediatric Extrapolation of GenSci006: A 3.75-mg Triptorelin Acetate Microsphere Formulation for Central Precocious Puberty.
Journal: Clinical pharmacokinetics
Published: November 17, 2025
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Data.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 22, 2025
Population Pharmacokinetics and Exposure-Response Analysis of Serplulimab in Small Cell Lung Cancer Patients.
Journal: Clinical and translational science
Published: May 20, 2025
Population pharmacokinetics and exposure-response modelling of firsekibart (GenSci048) in patients with acute gout flare: Implications for fixed-dose optimization.
Journal: British journal of clinical pharmacology
Published: May 06, 2025
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia.
Journal: Expert review of clinical pharmacology
Published: January 18, 2025
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.
Journal: Clinical and translational science
Published: January 07, 2025
Model informed dose regimen optimizing in development of leritrelvir for the treatment of mild or moderate COVID-19.
Journal: Frontiers in pharmacology
Published: June 15, 2024
Comprehensive population pharmacokinetic modelling of sugemalimab, an anti-programmed death-ligand 1 (PD-L1) human monoclonal antibody, in patients with solid tumours or lymphomas across multiple Phase I-III studies.
Journal: British journal of clinical pharmacology
Published: March 08, 2024
Dose finding for ZSP1601 in patients with nonalcoholic steatohepatitis using population pharmacokinetics and exposure-response approach.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: February 28, 2024
Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: October 23, 2023
Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus.
Journal: Clinical pharmacokinetics
Published: June 29, 2023
Last Updated: 09/26/2026